These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22520951)

  • 21. The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer.
    Ding M; Zhang H; Li Z; Wang C; Chen J; Shi L; Xu D; Gao Y
    Clin Exp Pharmacol Physiol; 2015 May; 42(5):458-64. PubMed ID: 25739318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation.
    Fujii S; Ito K; Ito Y; Ochiai A
    J Biol Chem; 2008 Jun; 283(25):17324-32. PubMed ID: 18430739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of EZH2 expression and its correlations with lung cancer patients' clinical pathological characteristics.
    Wan L; Li X; Shen H; Bai X
    Clin Transl Oncol; 2013 Feb; 15(2):132-8. PubMed ID: 22855181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EZH2 is a sensitive marker of malignancy in salivary gland tumors.
    Hajósi-Kalcakosz S; Vincze E; Dezső K; Paku S; Rókusz A; Sápi Z; Tóth E; Nagy P
    Diagn Pathol; 2015 Sep; 10():163. PubMed ID: 26377323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EZH2 promotes gastric cancer cells proliferation by repressing p21 expression.
    Xu J; Wang Z; Lu W; Jiang H; Lu J; Qiu J; Ye G
    Pathol Res Pract; 2019 Jun; 215(6):152374. PubMed ID: 30952377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2).
    Changchien YC; Tátrai P; Papp G; Sápi J; Fónyad L; Szendrői M; Pápai Z; Sápi Z
    J Transl Med; 2012 Oct; 10():216. PubMed ID: 23110793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profile of the polycomb group protein enhancer of Zeste homologue 2 and its prognostic relevance in renal cell carcinoma.
    Hinz S; Weikert S; Magheli A; Hoffmann M; Engers R; Miller K; Kempkensteffen C
    J Urol; 2009 Dec; 182(6):2920-5. PubMed ID: 19846140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.
    Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T
    Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome.
    Gong Y; Huo L; Liu P; Sneige N; Sun X; Ueno NT; Lucci A; Buchholz TA; Valero V; Cristofanilli M
    Cancer; 2011 Dec; 117(24):5476-84. PubMed ID: 21713757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma.
    Yonemitsu Y; Imazeki F; Chiba T; Fukai K; Nagai Y; Miyagi S; Arai M; Aoki R; Miyazaki M; Nakatani Y; Iwama A; Yokosuka O
    Hum Pathol; 2009 Sep; 40(9):1304-11. PubMed ID: 19386347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis.
    Wang X; Hu B; Shen H; Zhou H; Xue X; Chen Y; Chen S; Han Y; Yuan B; Zhao H; Zhi Q; Kuang Y
    Biomed Pharmacother; 2015 Oct; 75():218-25. PubMed ID: 26271144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct.
    Sasaki M; Matsubara T; Yoneda N; Nomoto K; Tsuneyama K; Sato Y; Nakanuma Y
    Histopathology; 2013 Feb; 62(3):446-57. PubMed ID: 23163606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma.
    Toll AD; Dasgupta A; Potoczek M; Yeo CJ; Kleer CG; Brody JR; Witkiewicz AK
    Hum Pathol; 2010 Sep; 41(9):1205-9. PubMed ID: 20573371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Meng X; Huang Z; Wang R; Jiao Y; Li H; Xu X; Feng R; Zhu K; Jiang S; Yan H; Yu J
    Radiat Oncol; 2014 Aug; 9():188. PubMed ID: 25159232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.
    Saramäki OR; Tammela TL; Martikainen PM; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2006 Jul; 45(7):639-45. PubMed ID: 16575874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathological variables and biomarkers enhancer of zeste homologue 2, Ki-67 and minichromosome maintenance protein 7 as prognosticators in primarily endocrine-treated prostate cancer.
    Tolonen TT; Tammela TL; Kujala PM; Tuominen VJ; Isola JJ; Visakorpi T
    BJU Int; 2011 Nov; 108(9):1430-8. PubMed ID: 21592298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of B-cell-specific Moloney murine leukemia virus integration site 1 mRNA and protein in gastric cancer.
    Liu PW; Lin Y; Chen XY
    J Dig Dis; 2014 Apr; 15(4):166-73. PubMed ID: 24393364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study.
    Li AM; Dunham C; Tabori U; Carret AS; McNeely PD; Johnston D; Lafay-Cousin L; Wilson B; Eisenstat DD; Jabado N; Zelcer S; Silva M; Scheinemann K; Fryer C; Hendson G; Fotovati A; Hawkins C; Yip S; Dunn SE; Hukin J
    Cancer; 2015 May; 121(9):1499-507. PubMed ID: 25586788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.
    Tamagawa H; Oshima T; Numata M; Yamamoto N; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Yukawa N; Rino Y; Masuda M; Miyagi Y
    Eur J Surg Oncol; 2013 Jun; 39(6):655-61. PubMed ID: 23523318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.